A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic Melanoma
Conditions
Interventions
- DRUG: RO5185426
- DRUG: RO5185426
- DRUG: RO5185426
Sponsor
Hoffmann-La Roche